1[1]Longstreth J.Cutaneous malignant melanoma and ultraviolet radiation:a review[J].Cancer Metastasis Rev,1988,7(4):321-333.
2[2]Swain SM.Endocrine therapies of cancer[A].In:Chabner BA,Longo DI.Cancer Chemotherapy and Biotherapy:Principles and Practice[M].New York:Lippincott-Raven,1996.59-108.
3[3]Perry RR,Kang Y,Greaves B.Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells[J].Ann Surg Oncol,1995,2(3):238-245.
5Markovic SN, Erickson LA, Rao RO, et al. Malignant melanoma in the 21st century, part 1 :Epidemiology, risk factors, screening prevention and diagnosis [J]. Mayo Clinic Proceedings, 2007, 82 (3) :364-380.
6Jemal AI A,Murray T, Ward E,et al. Cancer statistics,2005[J]. Cancer J Clin,2005,55(1) : 10-30.
7Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. Cancer J Clin,2008,56(2) :71-96.
8Ishihara K, Saida T. Statistical profiles of malignant melanoma and other skin cancers in Japan 2007 update[J]. Int J Clin Oncol, 2008,13 ( 1 ) : 33-41.
9Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma[J]. Front Biosci,2006,11(1) : 1244 -1254.
